Magnetic Resonance Spectroscopy (MRS) is another advanced non-invasive MRI procedure conducted in conjunction with the MRI procedure and used to determine the chemical content of brain tissue. Magnetic Resonance Spectroscopy is similar to a standard MRI, which gives structural and anatomical imaging, but is used to evaluate the metabolic and biochemical properties of brain tissue: that is, specific metabolites within cells are measured.

These are further details that allow the clinician to more accurately describe the brain lesions and differentiate various disease processes, as well as to determine the viability of the tissue. MRI Spectroscopy has significant applications in the diagnosis of brain tumors, epilepsy, infection, metabolic disorders, neurodegenerative diseases, and demyelinating disorders. It is also very important for treatment planning and monitoring the patient's response to treatment.

Purpose of MRI Brain with Spectroscopy

1. Characterization of Brain Tumors

• Aids in the distinction of benign from malignant brain lesions
• Evaluates tumor grade using metabolite pattern
• Recognizes recurrent tumor following treatment as radiation necrosis vs tumor
• Helps to schedule biopsy, surgery, and other treatment options

2. Evaluation of Seizure Disorders

• Detects disruption of normal metabolism in tissues that are prone to seizures
• Enables accurate localization of the epileptic discharge area
• Assists patients in preparation for surgery when seizure activity is not controlled by medications

3. Assessment of Brain Infections

• Identifies metabolic changes typical of brain abscesses
• Is useful in separating infectious lesions from tumors in the brain
• AIDS in the assessment of various conditions, including tuberculomas, toxoplasmosis, and fungal infections.

4. Diagnosis of Metabolic and Neurodegenerative Disorders

• Identifies biochemical defects in mitochondrial disorders, leukodystrophies, and Alzheimer's diseases
• May detect changes in metabolism before typical structural changes are noted on a traditional MRI

5. Investigation of Demyelinating Diseases

• Assists in the diagnosis and evaluation of individuals with multiple sclerosis and other demyelinating diseases
• Analyses metabolic alterations at times of inflammation, axonal injury, and demyelination

6. Post-treatment Follow-up

• Records the reactions to surgery, chemotherapy, or radiotherapy
• Aids in the identification of any remaining or recurrent cancer
• Conducts analyses of change in brain substance due to treatment

Procedure for MRI Brain with Spectroscopy

Before the Scan

• Normal MRI safety screen taken.
• All metal is to be removed from the patient before the exam.
• Since it is not normally done while the patient is awake, there is no fasting.
• Let the radiology staff know if any implants have been placed in the body, previous brain surgery, pregnancy, or claustrophobia.
• Regular medications can be continued unless directed otherwise by the referring doctor.

During the Scan

• The patient is comfortably positioned on an MRI table with their head held in a special head coil.
• The first part of the scan is a conventional MRI.
• Spectroscopy is then performed by selecting a specific region of interest (voxel) or multiple regions within the brain. 
• This is a painless test and lasts about 45 minutes to an hour.
• It is important to stay perfectly still during the scanning process to ensure correct information about metabolism.
• Spectroscopy does not prescribe the use of contrast, but it can be used if further evaluation of a lesion is desired by MRI.

After the Scan

• If the patient has been sedated, normal activities can be resumed once they have fully recovered. 
• Patients who are sedated are monitored until clear.
• The spectroscopy data is processed and interpreted by a neuroradiologist.

How does MRI Spectroscopy Works?

By measuring for each naturally occurring metabolite the concentration of their unique chemical resonance frequencies, called chemical shifts, MRI spectroscopy can measure naturally occurring metabolites in brain tissue.

A unique peak is seen for each metabolite on the MR spectrum. The relative levels and size of these peaks offer information about the metabolism, integrity, inflammation, and activity of the tumor.

Key Metabolites Evaluated

N-acetylaspartate (NAA)

• Marker of healthy neurons
• Reduced in tumors, neurodegenerative diseases, infections, ischemia, and other conditions associated with neuronal loss

Choline (Cho)

• Marker of cell membrane turnover
• Elevated in tumors, active demyelination, inflammation, and rapid cell proliferation

Creatine (Cr)

• Reflects cellular energy metabolism
• Usually remains relatively stable and serves as a reference metabolite

Lactate

• Indicates anaerobic metabolism
• Elevated in brain abscesses, hypoxic injury, ischemia, and many high-grade tumors

Myo-inositol (mI)

• Considered a marker of glial cells
• Elevated in gliosis, Alzheimer's disease, and certain metabolic disorders

Lipids

• Indicate cell membrane breakdown and necrosis
• Elevated in high-grade tumors, necrotic tissue, and brain abscesses

Glutamate and Glutamine (Glx)

• Involved in excitatory neurotransmission
• Abnormal levels may be seen in hepatic encephalopathy, epilepsy, and metabolic disorders

Spectroscopy Techniques

Single Voxel Spectroscopy (SVS)

• Evaluates one selected region of the brain
• Provides a high signal-to-noise ratio
• Commonly used for the assessment of focal brain lesions

Multi Voxel Spectroscopy (MVS) or Chemical Shift Imaging (CSI)

• Evaluates multiple regions simultaneously
• Produces a metabolic map of the brain
• Useful for assessing tumor infiltration and diffuse brain disorders

Benefits of MRI Brain with Spectroscopy

• Provides a non-invasive assessment of brain metabolism
• Detects biochemical abnormalities not visible on routine MRI
• Improves characterization of brain tumors and treatment-related changes
• Supports early diagnosis of metabolic and neurodegenerative disorders
• Assists in biopsy planning, surgical decision-making, and treatment monitoring
• May reduce the need for invasive diagnostic procedures in selected cases

Conditions Commonly Evaluated with MRI Spectroscopy

• High-grade gliomas (including glioblastoma)
• Low-grade gliomas
• Metastatic brain tumors
• Primary central nervous system lymphoma
• Brain abscess
• Tuberculoma
• Multiple sclerosis
• Temporal lobe epilepsy
• Alzheimer's disease
• Mitochondrial disorders
• Leukodystrophies
• Hypoxic-ischemic brain injury

Risks and Limitations

MRI Safety

• MRI Spectroscopy is safe and does not use ionizing radiation.
• It may not be suitable for patients with certain MRI-incompatible implants or devices.
• Patients with severe claustrophobia may require sedation.

Technical Limitations

• Patient movement can significantly affect image and spectral quality.
• Very small lesions or lesions near the skull base may be difficult to evaluate accurately.
• Interpretation requires specialized software and experienced neuroradiologists.
• Results should always be interpreted alongside conventional MRI findings and the patient's clinical history.

Contrast Administration

• Contrast is generally not required for spectroscopy itself.
• Gadolinium contrast may be administered when additional characterization of brain lesions is clinically indicated.

Pediatric Considerations

• Imaging protocols are adjusted according to the child's age and clinical condition.
• Young children often require sedation to minimize movement during the examination.

Conclusion

Each of these imaging methods is a sophisticated version of the brain MRI technique, which on its own gives useful information, and combines with MRI spectroscopy to acquire useful information about the biochemical and metabolic (active metabolism) composition of brain tissue. It is essential to the diagnosis of brain tumors, epilepsy, infections, metabolic diseases, and degenerative diseases of the brain. MRI Spectroscopy can be used to characterize tissue metabolites and make the diagnosis, differentiate various brain lesions, determine disease severity, track treatment response, and make accurate clinical decisions. As it is non-invasive and can reveal metabolic abnormalities in advance of structural changes, it is an important part of the modern assessments and personalized care of patients using a neuro-imaging approach.